Hirsutism

Lancet

Volumn 349, Issue 9046, 1997, Pages 191-195

  Rittmaster, Roger S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANDROGEN; CYPROTERONE ACETATE; FLUTAMIDE; HYDROCORTISONE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; SPIRONOLACTONE;

DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS; HIRSUTISM; HUMAN; NAUSEA; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031033940     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07252-2     Document Type: Review

References (30)

1. Uno H. Biology of hair growth. Semin Reprod Endocrinol 1986; 4: 131-41.
2. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994; 63: 25-61.
3. Mauvais-Jarvis P. Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women. Clin Endocrinol Metab 1986; 15: 307-17.
4. Dunaif A. Insulin resistance and ovarian hyperandrogenism. The Endocrinologist 1992; 2: 248-60.
5. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-47.
6. McKnight E. The prevalence of "hirsutism" in young women. Lancet 1964; i: 410-13.
7. Lunde O. A study of body hair density and distribution in normal women. Am J Phys Anthropol 1984; 64: 179-84.
8. New M, White PC, Pang S, Dupont B, Speiser PW. The adrenal hyperplasias. In: Scriver CL, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th edn. New York: McGraw-Hill, 1989: 1881-918.
9. Chetkowski RJ, DeFazio J, Shamonki I, Judd HL, Chang RJ. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 1984; 58: 595-98.
10. Tagatz GE, Kopher RA, Nagel TC, Okagaki T. The clitoral index: a bioassay of androgenic stimulation. Obstet Gynecol 1979; 54: 562-64.
11. Dunaif A, Green K, Phelps RG, Lebwohl M, Futterweit W, Lewy L. Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological and biochemical findings. J Clin Endocrinol Metab 1991; 75: 590-95.
12. Azziz R, Zacur HA. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 1989; 69: 577.
13. Rittmaster RS. Evaluation and treatment of hirsutism. Infertil Reprod Med Clin North Am 1991; 2: 511-29.
14. Crosby PDA, Rittmaster RS. Predictors of clinical response in hirsute women treated with spironolactone. Fertil Steril 1991; 55: 1076-81.
15. Rittmaster RS. Use of GnRH agonists in the treatment of hyperandrogenism. Clin Obstet Gynecol 1993; 36: 679-89.
16. Azziz R, Ochoa TM, Bradley ELJ, Potter HD, Boots LR. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab 1995; 80: 3406-11.
17. Heiner JS, Greendale GA, Kawakami AK, et al. Comparison of a GnRH agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism. J Clin Endocrinol Metab 1995; 80: 3412-18.
18. Steinberger E, Rodriguez-Rigau LJ, Petak SM, Weidman ER, Smith KD, Ayala C. Glucocorticoid therapy hyperandrogenism. Clin Obstet Gynecol 1990; 4: 457-71.
19. Spritzer P, Billaud L, Thalabard JC, et al. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1990; 70: 642-45.
20. Eil C, Edelson SK. The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metab 1984; 59: 51-55.
21. Lobo RA, Shoupe D, Serafini P, Brinton D, Horton R. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril 1985; 43: 200-05.
22. Helfer EL, Miller JL, Rose LI. Side-effects of spironolactone therapy in the hirsute woman. J Clin Endocrinol Metab 1988; 66: 208-11.
23. Groves TD, Corenblum B. Spironolactone therapy during human pregnancy. Am J Obstet Gynecol 1995; 172: 1655-56.
24. Miller JA, Jacobs HS. Treatment of hirsutism and acne with cyproterone acetate. Clin Endocrinol Metab 1986; 15: 373-89.
25. O'Brien RC, Cooper ME, Murray RML, Seeman E, Thomas AK, Jerums G. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism. J Clin Endocrinol Metab 1991; 72: 1008-13.
26. Cusan L, Dupont A, Gomez J-L, Tremblay R, Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomised controlled trial. Fertil Steril 1994; 61: 281-87.
27. Erenus M, Gurbuz O, Durmusoglu F, Demircay Z, Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 1994; 61: 613-16.
28. Wysowski DK, Fourcroy JL. Safety of flutamide? Fertil Steril 1994; 62: 1089-90.
29. Rittmaster RS. Finasteride. N Engl J Med 1994; 330: 120-25.
30. Wong IL, Morris RS, Chang L, Spahn M-A, Stanczyk FZ, Lobo RA. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsutism. J Clin Endocrinol Metab 1995; 80: 233-38.